Search alternatives:
significantly increased » significant increase (Expand Search)
significant baseline » significant decline (Expand Search), significant based (Expand Search), significant barrier (Expand Search)
baseline differences » based differences (Expand Search), examine differences (Expand Search), xlink differences (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
significantly increased » significant increase (Expand Search)
significant baseline » significant decline (Expand Search), significant based (Expand Search), significant barrier (Expand Search)
baseline differences » based differences (Expand Search), examine differences (Expand Search), xlink differences (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
Significant regions between focused conditions and the baseline in disyllabic targets (the darkest part of the bar indicates regions of significant differences; the dark grey part indicates regions of marginal significance; the light grey part signals regions of no significant differences; the labels of y axis indicate various focus conditions compared to the baseline, n = narrow focus, c = contrastive focus).
Published 2023“…<p>Significant regions between focused conditions and the baseline in disyllabic targets (the darkest part of the bar indicates regions of significant differences; the dark grey part indicates regions of marginal significance; the light grey part signals regions of no significant differences; the labels of y axis indicate various focus conditions compared to the baseline, n = narrow focus, c = contrastive focus).…”
-
151
-
152
Top 10 significantly changed metabolites and lipids in each clinical outcome measure group.
Published 2023“…The orange color indicates increase in levels and the blue color represent decrease in levels. …”
-
153
-
154
CUMS or smoke decreased protein concentration of BDNF, but increased TrkB and P75.
Published 2022Subjects: -
155
Baseline characteristics.
Published 2024“…Clinical progression of COVID-19 ARDS was not statistically different between glenzocimab and placebo arms (43.3% and 29.0%, respectively; <i>p = 0</i>.<i>245</i>). Decrease in the NEWS-2 category at D4 was statistically significant (<i>p = 0</i>.…”
-
156
-
157
-
158
-
159
-
160
Gut composition changes significantly during chemoradiotherapy, adapts after treatment, and remains altered at first follow-up.
Published 2021“…After chemoradiotherapy (between week 5 and week 12; C), proteobacteria decreased, whereas Ezakiella increased. Overall, the most significant alteration between baseline and first chemoradiotherapy follow-up (week 12; D) was an increase in Bacteroidales.…”